Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Rentschler implements innovative learning program in collaboration with MassBioEd and WPI
December 07, 2022 09:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board
November 21, 2022 11:30 ET
|
Rentschler Biopharma SE
Dr. Frank Mathias joined Rentschler Biopharma SE’s Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016. LAUPHEIM, Germany, Nov. 21,...
Rentschler Biopharma appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board
November 16, 2022 04:00 ET
|
Rentschler Biopharma SE
Company increases focus on core operationsChristiane Bardroff to head global clinical and commercial manufacturing, engineering and technology operations, as well as production automation LAUPHEIM,...
Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility
August 18, 2022 09:03 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma adds highly experienced executive to team and provides update on progress at Rentschler ATMP
June 13, 2022 10:00 ET
|
Rentschler Biopharma SE
Company hires Kassim Kolia, as Vice President, Business Development to grow cell and gene therapy businessStevenage ATMP site projected to be client ready for process development in late 2022 ...
Rentschler Biopharma reports strong growth and continues hiring at all three sites
December 20, 2021 07:00 ET
|
Rentschler Biopharma SE
Over 300 new team members in 2021, additional new positions planned at all sitesRentschler Biopharma again named one of “most attractive employers” in Germany by the F.A.Z. Institute and awarded first...
Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm
September 22, 2021 07:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and ULM, Germany, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
August 12, 2021 08:00 ET
|
Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
March 31, 2021 04:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
March 22, 2021 05:00 ET
|
Rentschler Biopharma SE
Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...